Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple myeloma.

E Ascari1, G Merlini, A Riccardi

  • 1Dipartimento di Medicina Interna e Terapia Medica, Università degli Studi Pavia, Italy.

Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|July 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus.

Lupus·2019
Same author

Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study.

Clinical and experimental medicine·2019
Same author

Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.

Lupus·2017
Same author

Targeting the EWS-FLI1 transcription factor in Ewing sarcoma.

Cancer chemotherapy and pharmacology·2015
Same author

Identification of the hydration state in emergency patients: correlation between caval index and BUN/creatinine ratio.

European review for medical and pharmacological sciences·2013
Same author

DNA-ploidy and proliferative activity in uterine-tumors - an in-vivo study using bromodeoxyuridine and flow-cytometry.

Oncology reports·2011
Same journal

[Bronchiectasis worsening by p-ANCA (bactericidal/permeability-increasing protein) positive vasculitis. A case report and review of the literature].

Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna·2006
Same journal

[Celiac disease in the elderly: a case report].

Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna·2006
Same journal

Severe bleeding in a case of acquired factor VIII inhibitor associated with generalized pustular psoriasis.

Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna·2006
Same journal

Soft tissue infection caused by Mycobacterium chelonae following a liposculpture and lipofilling procedure.

Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna·2006
Same journal

[Characteristics of patients admitted to a Division of Internal Medicine. Is hospital the best setting of care?].

Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna·2006
Same journal

[Depression in patients with cardiovascular disease].

Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna·2006
See all related articles

Multiple myeloma (MM) is a cancer of plasma cells. Current treatments include chemotherapy and supportive care, with bisphosphonates aiding bone disease management.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Multiple myeloma (MM) arises from malignant B-lymphocyte expansion, often involving oncogenes.
  • MM cells exhibit a hybrid phenotype, contributing to associated disorders and cytokine production.
  • Interleukin-6 and immune mechanisms control plasma cell differentiation and monoclonal component secretion.

Purpose of the Study:

  • To review the pathophysiology, clinical manifestations, and current treatment strategies for multiple myeloma.
  • To highlight prognostic indicators and supportive care in managing MM.
  • To discuss emerging therapeutic approaches and supportive care tools like bisphosphonates.

Main Methods:

  • Literature review of multiple myeloma pathogenesis, clinical features, and treatment modalities.

Related Experiment Videos

  • Analysis of prognostic factors including serum beta-2-microglobulin and bone marrow labeling index.
  • Evaluation of current and investigational therapies, including induction and second-line treatments.

    • Main Results:

    • MM signs stem from tumor proliferation (bone disease, inhibited hematopoiesis) and monoclonal component damage (renal failure, neurological issues).
    • Prognosis is best estimated by serum beta-2-microglobulin and bone marrow labeling index.
    • Standard induction therapy uses alkylating agents with prednisone; second-line options include VAD or pulsed glucocorticoids.

    Conclusions:

    • Effective curative regimens for MM are lacking, emphasizing the importance of supportive care.
    • Bisphosphonates are valuable for managing myeloma bone disease.
    • Ongoing research explores novel therapies, but their efficacy requires further validation.